Since NASH also manifests hepatic fibrosis, we also analyzed two fibrosis markers — alpha-smooth muscle actin (α-SMA) and TIMP1, in liver sections. Here, ACTA1 is linked to metabolic dysfunction-associated steatohepatitis.